When compared to other cancers, although the PI3K-AKT pathway presents a relatively low overall mutation rate in ccRCC, the overall activation (phosphorylation levels) of AKT and downstream substrates is high [24–26]. Here, AKT1 is linked to nonpapillary renal cell carcinoma.